In re Horizon Organic Milk Plus Dha Omega-3 Marketing & Sales Practice Litigation
955 F. Supp. 2d 1311
S.D. Fla.2013Background
- Multidistrict litigation consolidating seven consumer class actions (plaintiffs from AZ, AR, CA, FL, IL, MO) against WhiteWave Foods (Dean Foods subsidiary) over labeling and advertising that its DHA-fortified milk “supports brain health.”
- Plaintiffs allege the DHA in WhiteWave’s milk does not support brain health and that WhiteWave lacked competent scientific evidence; they paid a premium and assert consumer fraud, unjust enrichment, and breach of express warranty claims under various state laws.
- WhiteWave moved to dismiss (or strike class allegations), arguing: lack of private standing to challenge scientific substantiation, primary jurisdiction and deference to FDA/FTC, statutory safe-harbors, failure to plead deception with particularity (Rule 9(b)), lack of consumer injury, and that class claims are uncertifiable.
- Plaintiffs replied they allege affirmative falsity (not mere lack of substantiation), reliance and economic injury (premium paid), and that FTC/FDA letters do not constitute agency approval or safe-harbor protection.
- The Court accepted plaintiffs’ well-pleaded factual allegations as true for the motion to dismiss, denied dismissal of most state-law claims (consumer fraud statutes, unjust enrichment, many express-warranty claims), rejected the safe-harbor and primary-jurisdiction arguments, denied striking class allegations as premature, and dismissed one California breach-of-express-warranty count for failure to plead pre-suit notice (with leave to amend).
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Sufficiency of consumer-fraud pleadings / Rule 9(b) | Plaintiffs allege labels/ads are actually false; pleaded who, what, where, when, reliance, and premium injury | WhiteWave contends claims are impermissible "lack of substantiation" claims, fail Rule 9(b), and lack injury | Court: Plaintiffs adequately pleaded falsity, reliance, injury and satisfied Rule 9(b); consumer-fraud claims survive dismissal |
| Safe-harbor / agency letters (FDA/FTC) | Plaintiffs: agency letters are not formal approvals and do not bar private claims | WhiteWave: FDA/FTC letters mean claims are authorized or not subject to state-law suits under statutory safe harbors | Court: FDA/FTC letters did not constitute formal approval or legal authorization; statutory safe-harbors do not bar these claims at pleading stage |
| Primary jurisdiction (defer to FDA/FTC) | Plaintiffs: falsity and consumer-deception are within courts’ competence; FDA has shown little interest | WhiteWave: technical/scientific issues about DHA belong to agencies | Court: primary jurisdiction inapplicable — disputes about misleading advertising are within court experience; no showing that agency expertise or uniformity requires referral |
| Motion to strike class allegations | Plaintiffs: premature; class certification is a later factual inquiry | WhiteWave: individualized issues will defeat class treatment | Court: motion to strike is premature; deny without prejudice pending certification stage |
Key Cases Cited
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (pleading must state plausible claim)
- Ashcroft v. Iqbal, 556 U.S. 662 (courts accept well-pleaded factual allegations and disregard conclusions)
- Ziemba v. Cascade Intern., Inc., 256 F.3d 1194 (11th Cir.) (Rule 9(b) particularity standards for fraud)
- Am. Dental Ass’n v. Cigna Corp., 605 F.3d 1283 (11th Cir.) (two-pronged Iqbal/Twombly approach applied)
- Van Dusen v. Barrack, 376 U.S. 612 (choice-of-law rules follow transferor forum in MDL context)
- Erie R.R. Co. v. Tompkins, 304 U.S. 64 (federal courts apply state substantive law)
- Reiter v. Cooper, 507 U.S. 258 (primary jurisdiction: doctrine and effect)
- United States v. Western Pac. R.R., 352 U.S. 59 (primary jurisdiction principles)
- Cel-Tech Commc’ns, Inc. v. Los Angeles Cellular Tel. Co., 20 Cal.4th 163 (Cal. law recognizing safe-harbor concept in UCL context)